Illumina to Unwind Grail Merger
- December 22, 2023
After battling U.S. and European antitrust regulators for months, genetic sequencing firm Illumina Inc. said December 17 that it has decided to shed cancer detection company Grail through a third-party sale or capital markets transaction.
ARTICLE TAGS
You must be logged in to access this content.